Cocaine self-administration is increased by both D1 and D2 dopamine antagonists
- PMID: 1838414
- DOI: 10.1016/0091-3057(91)90168-2
Cocaine self-administration is increased by both D1 and D2 dopamine antagonists
Abstract
Rats were trained to self-administer cocaine on a fixed-ratio 5 schedule of reinforcement with a 1-min time-out period following each infusion. Cocaine was available at doses of either 0.1, 0.3 or 1.0 mg/kg/infusion. A low dose (3 microgram/kg) of the D1 antagonist SCH23390 caused an increase in cocaine self-administration which was more prominent at higher, as compared to lower, doses of cocaine. Higher doses of SCH23390 generally caused decreases in self-administration which may in part be due to the response-decreasing properties of this agent. The D2 antagonist spiperone generally caused an increase in self-administration of cocaine. These data suggest that cocaine reinforcement depends upon both D1 and D2 receptor subtypes.
Similar articles
-
Clinical neuropharmacology of cocaine reinforcement: A narrative review of human laboratory self-administration studies.J Exp Anal Behav. 2022 May;117(3):420-441. doi: 10.1002/jeab.744. Epub 2022 Mar 1. J Exp Anal Behav. 2022. PMID: 35229294 Free PMC article. Review.
-
Effects of selective D1 and D2 dopamine antagonists on cocaine self-administration in the rat.Psychopharmacology (Berl). 1991;105(2):151-6. doi: 10.1007/BF02244301. Psychopharmacology (Berl). 1991. PMID: 1839063
-
Effects of dopamine indirect agonists and selective D1-like and D2-like agonists and antagonists on cocaine self-administration and food maintained responding in rats.Neuropharmacology. 2004;47 Suppl 1:256-73. doi: 10.1016/j.neuropharm.2004.07.007. Neuropharmacology. 2004. PMID: 15464142
-
The D1 dopamine receptor antagonist SCH 23390 increases cocaine self-administration in the rat.Neurosci Lett. 1987 Aug 31;79(3):315-20. doi: 10.1016/0304-3940(87)90451-4. Neurosci Lett. 1987. PMID: 2958724
-
Biphasic reward effects are characteristic of both lorcaserin and drugs of abuse: implications for treatment of substance use disorders.Behav Pharmacol. 2022 Jun 1;33(4):238-248. doi: 10.1097/FBP.0000000000000672. Epub 2022 Mar 23. Behav Pharmacol. 2022. PMID: 35324488 Free PMC article. Review.
Cited by
-
Clinical neuropharmacology of cocaine reinforcement: A narrative review of human laboratory self-administration studies.J Exp Anal Behav. 2022 May;117(3):420-441. doi: 10.1002/jeab.744. Epub 2022 Mar 1. J Exp Anal Behav. 2022. PMID: 35229294 Free PMC article. Review.
-
Attenuation of relapse to cocaine seeking by dopamine D1 receptor agonists and antagonists in non-human primates.Psychopharmacology (Berl). 2003 Jul;168(1-2):124-131. doi: 10.1007/s00213-002-1365-y. Epub 2003 Feb 27. Psychopharmacology (Berl). 2003. PMID: 12607074
-
SDZ 208-911, an amino-ergoline with partial dopamine agonist properties, dose dependently increases cocaine self-administration in the rat.Psychopharmacology (Berl). 1994 Jan;113(3-4):518-20. doi: 10.1007/BF02245232. Psychopharmacology (Berl). 1994. PMID: 7862868
-
Dopamine signaling in the nucleus accumbens of animals self-administering drugs of abuse.Curr Top Behav Neurosci. 2010;3:29-71. doi: 10.1007/7854_2009_27. Curr Top Behav Neurosci. 2010. PMID: 21161749 Free PMC article. Review.
-
Developmental lead exposure alters methamphetamine self-administration in the male rat: acquisition and reinstatement.Drug Alcohol Depend. 2008 May 1;95(1-2):23-9. doi: 10.1016/j.drugalcdep.2007.12.003. Epub 2008 Feb 1. Drug Alcohol Depend. 2008. PMID: 18242880 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources